<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04574414</url>
  </required_header>
  <id_info>
    <org_study_id>KE_24042019A</org_study_id>
    <nct_id>NCT04574414</nct_id>
  </id_info>
  <brief_title>Determining the Impact of Air Pollution on the Developing Brain</brief_title>
  <acronym>NeuroSmog</acronym>
  <official_title>NeuroSmog: Determining the Impact of Air Pollution on the Developing Brain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Environmental Protection - National Research Institute (IOS-PIB)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foundation for Polish Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Background: Recent studies have linked exposure to airborne particulate matter (PM) to&#xD;
           neurodevelopmental outcomes but the findings are mixed and mechanisms are unclear. We&#xD;
           aim to determine the impact of PM on the developing brain of schoolchildren in Poland, a&#xD;
           European country characterized by very high levels of air pollution. The investigators&#xD;
           aim to determine the impact of PM on the developing brain of schoolchildren in Poland, a&#xD;
           European country characterized by very high levels of air pollution.&#xD;
&#xD;
        -  Study area: 19 towns in three voivodeships (Lesser Poland, Silesian, Opole) in the&#xD;
           southern Poland. To reduce confounding by urbanicity and at the same time, to achieve&#xD;
           sufficient contrasts in PM levels without too high logistic costs, towns were selected&#xD;
           by size (big and small) and by PM levels (high, medium and low).&#xD;
&#xD;
        -  Design: Case-control study with 800 children recruited over two school years, with two&#xD;
           population controls per one ADHD case. Suspected cases will be recruited in specialized&#xD;
           facilities and presumably ADHD-free children will be recruited in primary schools.&#xD;
&#xD;
        -  Exposure assessment: Poland-wide PM and other air pollutants' grids will be created for&#xD;
           the years 2006 to 2021 using statistical models to incorporate land use data, estimates&#xD;
           from transport models, satellite observations and air pollution measurements from Polish&#xD;
           monitoring network. Prenatal, early-life, lifelong and concurrent exposures will be&#xD;
           calculated.&#xD;
&#xD;
        -  Psychological testing: Every child and their parents will complete a series of&#xD;
           psychological tests and interviews that will be conducted during their three visits to&#xD;
           the recruitment facility.&#xD;
&#xD;
        -  Neuroimaging: Each participant will undergo a Magnetic Resonance Imaging (MRI) scanning&#xD;
           session that will be performed accordingly to the Human Connectome Adolescent Brain&#xD;
           Cognitive Development project recommendations. Scanning will be performed on a single&#xD;
           scanner in Krakow.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Attention Deficit Hyperactivity Disorder (ADHD)</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>ADHD and comorbidities will be assessed by Conners 3 questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive functioning</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Memory, attention, and executive functions measurement will be assessed by Diagnostic battery for cognitive functions evaluation (PU1)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attention control</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Attention Network Test (ANT) will be used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sustained and selective attention</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Computer Conners Continuous Performance Task (CPT) will be used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibition control</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Conditioned Approach Response Inhibition Task (CARIT) will be used as part of MRI measurements.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inhibition control</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Go/No Go task will be used as part of MRI measurements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Full-Scale Intelligence Quotient (IQ)</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>IQ will be measured by Stanford-Binet Intelligence Scales, 5th Edition (SB5).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Family functioning</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Polish adaptation of the FACES-IV (Flexibility and Cohesion Evaluation Scales; SOR) will be used to estimate social functioning of the children (family functioning).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationships with siblings</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Siblings Relationship Questionnaire (KRR), which is a supplement for the SOR Scale will be used to assess social functioning of the children (relationships with siblings).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural, emotional, and social problems</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Youth Self-Report Scale (YSR) will be used for this assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural problems</measure>
    <time_frame>October 1, 2020 until December 31, 2022</time_frame>
    <description>Child Behaviour Checklist (CBCL) questionnaire will collect information on the eight syndrome domains: anxious/depressed, depressed, somatic complaints, social problems, thought problems, attention problems, rule-breaking behaviour, aggressive behaviour</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <condition>Attention</condition>
  <condition>Executive Functioning</condition>
  <condition>Social Functioning</condition>
  <arm_group>
    <arm_group_label>Children with Attention Deficit Hyperactivity Disorder</arm_group_label>
    <description>Cases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children without Attention Deficit Hyperactivity Disorder</arm_group_label>
    <description>Population controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Psychological testing and MRI imaging</intervention_name>
    <description>Every child will have three sessions with psychologists and be diagnosed as having or not having ADHD.&#xD;
Every child will be invited to Krakow to undergo MRI measurements, including resting-state and event-related functional MRI, Diffusion Tensor Imaging (DTI), and T1/T2 structural MRI.</description>
    <arm_group_label>Children with Attention Deficit Hyperactivity Disorder</arm_group_label>
    <arm_group_label>Children without Attention Deficit Hyperactivity Disorder</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        800 children aged 10-13 will be sampled to the NeuroSmog study. Both ADHD cases and&#xD;
        population controls will be enrolled, two control per case. Cases will be recruited in&#xD;
        specialized facilities and controls will be randomly sampled in randomly selected 30&#xD;
        primary schools across 19 big and small towns in Lesser Poland, Silesian and Opole&#xD;
        voivodeships in the southern Poland.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Attending school in one of the specified towns&#xD;
&#xD;
          -  Age 10-13 years (4th-6th grade)&#xD;
&#xD;
          -  Native Polish speaker&#xD;
&#xD;
          -  Normal or above intelligence&#xD;
&#xD;
          -  Standard educational opportunities&#xD;
&#xD;
          -  Normal or corrected to normal visual and auditory acuity&#xD;
&#xD;
          -  No gross sensory deficit, no gross behavioural problems&#xD;
&#xD;
          -  No history of neurological disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Autism spectrum disorder (ASD)&#xD;
&#xD;
          -  FAS&#xD;
&#xD;
          -  FAE&#xD;
&#xD;
          -  Intellectual disability&#xD;
&#xD;
          -  Metabolic disorders&#xD;
&#xD;
          -  Genetic disorders&#xD;
&#xD;
          -  Epilepsy&#xD;
&#xD;
          -  Cerebral palsy&#xD;
&#xD;
          -  Mood disorders&#xD;
&#xD;
          -  Tourette Syndrome&#xD;
&#xD;
          -  Other illnesses including pharmacotherapy&#xD;
&#xD;
          -  Apgar score &lt; 8&#xD;
&#xD;
          -  Low birth weight (below 2500 g)&#xD;
&#xD;
          -  Preterm birth (below 35th weeks of gestation)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marcin Szwed, Dr. hab.</last_name>
    <phone>12 663 24 40</phone>
    <phone_ext>+48</phone_ext>
    <email>m.szwed@uj.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Iana Markevych, PhD</last_name>
    <email>iana.markevych@uj.edu.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Psychology</name>
      <address>
        <city>Krak√≥w</city>
        <zip>30-060</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2020</study_first_posted>
  <last_update_submitted>September 28, 2020</last_update_submitted>
  <last_update_submitted_qc>September 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Marcin Szwed</investigator_full_name>
    <investigator_title>Leader of the NeuroSmog consortium</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

